Streetbeat News

Earnings

XXII

22nd Century Group (XXII) reported Q1 sales of $21.96 million, up 30.82% from Q4, but still posted a loss of $18.18 million. The company's Return on Capital Employed (ROCE) was -0.22%, suggesting inefficient capital allocation. Q1 earnings per share were $-0.08, missing analyst predictions of $-0.07.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:52 pm

SCSC

ScanSource (NASDAQ:SCSC) reported Q3 earnings of $21.22 million, a 17.54% increase from Q2, while sales dropped 12.41% to $885.52 million. The company posted a return on capital employed (ROCE) of 0.02%, indicating effective capital allocation.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:51 pm

LITE

Lumentum Holdings (NASDAQ:LITE) reported Q3 sales of $383.4 million and a loss of $39.3 million, a 23.97% decrease from last quarter. The company posted a negative Return on Capital Employed (ROCE) of -0.03%, suggesting inefficient capital allocation.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:51 pm

MCRB

Seres Therapeutics (NASDAQ:MCRB) reported Q1 sales of $-522 thousand and a loss of $71.17 million, a 3.46% decrease from last quarter. The company posted a return on capital employed (ROCE) of 1.49%, suggesting effective capital allocation. However, Q1 earnings per share of $-0.57 did not meet analyst predictions of $-0.55.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:50 pm

MRSN

Mersana Therapeutics reported Q1 sales of $7.80 million and a loss of $56.16 million, a 25.02% decrease from last quarter. The company posted a negative ROCE of -0.87%, suggesting inefficient capital allocation. Q1 earnings per share were $-0.52, missing analyst predictions of $-0.44.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:50 pm

NVAX

Novavax reported Q1 sales of $80.95 million and a loss of $293.90 million, a 61.27% decrease from last quarter. The company posted a return on capital employed (ROCE) of 0.33%, indicating effective capital allocation. Q1 earnings per share were $-3.41, beating analyst predictions of $-3.46.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:48 pm

KOS

Kosmos Energy (NYSE:KOS) reported Q1 earnings of $83.31 million, a 172.9% increase from Q4, while sales dropped 30.13% to $393.87 million. The company posted a return on capital employed (ROCE) of 0.1%, indicating effective capital allocation. However, Q1 earnings per share of $0.16 did not meet analyst predictions of $0.17.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:47 pm

LCII

LCI Indus (NYSE:LCII) reported a 142.38% increase in earnings to $7.26 million and an 8.83% increase in sales to $973.31 million during Q1. The company posted a positive return on capital employed (ROCE) of 0.01%, indicating effective capital allocation. Q1 earnings per share were $0.29, beating analyst predictions of -$0.02.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:47 pm

NOVT

Novanta (NASDAQ:NOVT) reported Q1 earnings of $18.27 million, a 19.68% increase from the previous quarter, and sales of $219.13 million, a 0.34% increase since Q4. The company posted a return on capital employed (ROCE) of 0.03%, indicating effective capital allocation.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:46 pm

FSR

Fisker reported Q1 sales of $198 thousand and a loss of $120.56 million, with a return on capital employed (ROCE) of -0.3%. The negative ROCE suggests that management may not be effectively allocating their capital.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 2:46 pm